Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 25, Issue 11, Pages 1327-1340
Publisher
Baishideng Publishing Group Inc.
Online
2019-03-19
DOI
10.3748/wjg.v25.i11.1327
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost Effectiveness of Pre– vs Post–Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals
- (2018) Sumeyye Samur et al. Clinical Gastroenterology and Hepatology
- Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan
- (2018) Z. M. Younossi et al. JOURNAL OF VIRAL HEPATITIS
- Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece
- (2017) Ilias Gountas et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India
- (2017) Rakesh Aggarwal et al. PLoS One
- Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden
- (2016) Zobair Younossi et al. GASTROENTEROLOGY
- The Impact of Age on Fibrosis Progression in Chronic Hepatitis C Patients
- (2016) I. Gountas et al. JOURNAL OF HEPATOLOGY
- Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus
- (2016) Z. M. Younossi et al. JOURNAL OF VIRAL HEPATITIS
- Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States
- (2016) Zobair M. Younossi et al. MEDICINE
- Mental and Emotional Impairment in Patients With Hepatitis C is Related to Lower Work Productivity
- (2016) Issah Younossi et al. PSYCHOSOMATICS
- Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population
- (2016) Harinder S. Chahal et al. JAMA Internal Medicine
- Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies
- (2015) C. Estes et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2
- (2015) E. Gane et al. JOURNAL OF VIRAL HEPATITIS
- The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2
- (2015) A. Hatzakis et al. JOURNAL OF VIRAL HEPATITIS
- Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2
- (2015) V. Saraswat et al. JOURNAL OF VIRAL HEPATITIS
- Thresholds for the cost–effectiveness of interventions: alternative approaches
- (2015) Elliot Marseille et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
- (2014) H. Razavi et al. JOURNAL OF VIRAL HEPATITIS
- Strategies to manage hepatitis C virus (HCV) disease burden
- (2014) H. Wedemeyer et al. JOURNAL OF VIRAL HEPATITIS
- Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma
- (2014) Athina Chounta et al. LIVER INTERNATIONAL
- Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Cost-Of-Illness Analysis of Hepatitis C in Greece
- (2013) K. Athanasakis et al. VALUE IN HEALTH
- Chronic hepatitis C virus (HCV) disease burden and cost in the United States
- (2012) Homie Razavi et al. HEPATOLOGY
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Economic burden of hepatitis C-associated diseases in the United States
- (2011) A. C. El Khoury et al. JOURNAL OF VIRAL HEPATITIS
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
- (2009) Gary L. Davis et al. GASTROENTEROLOGY
- Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
- (2008) Hla-Hla Thein et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started